Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

First-year students encouraged to attend UFS welcoming function
2007-01-12

Main Campus, Bloemfontein
The University of the Free State (UFS) will host a welcoming function for all new first-year students and their parents on Saturday 13 January 2007 in the Callie Human Centre on the Main Campus in Bloemfontein.
 
The function starts at 11:00 and will be addressed by the Rector and Vice-Chancellor of the UFS, Prof Frederick Fourie. UFS staff will also be available to provide vital information to first-year students on academic matters.
 
Saturday’s welcoming function can assist students and parents by providing vital information on the registration process, which starts on Tuesday 16 January 2007, and the many high quality academic learning programmes on offer in six faculties at the UFS.
 
The UFS has split the registration process into various categories of students and students should adhere to the dates, and times which apply to them as a one-stop service will be available so as to avoid unnecessary delays in the registration process.
 
The registration of first-time entering first-year students who applied before 30 November 2006 to study at the Bloemfontein Campus will take place from Tuesday 16 January 2007 at the Callie Human Centre.
 
Senior undergraduate students (that is, students entering their second or later year of study) may register from 22 January 2007 according to a programme that was sent to all students who were registered at the UFS in 2006.
 
Postgraduate students, first-time entering first-year students and other students, who applied for admission to the Main Campus after 30 November 2006 and were accepted, must register at the Callie Human from 5 February 2007. 
 
Late applications will be accepted until Monday 15 January 2007 at the Information Centre on the Main Campus’ Thakaneng Bridge. 
 
Lectures will commence on 5 February 2007 and the registration process will end on 9 February 2007.
 
Vista Campus:
The Vista Campus in Bloemfontein – which was incorporated into the UFS in January 2004 – no longer accepts applications from first-year students. Such prospective students had to apply to the UFS Main Campus. Students who had been registered on the Vista Campus last year must register at the Vista Campus on the same dates as applicable on the Main Campus.
 
Qwaqwa Campus:
At the Qwaqwa Campus of the UFS all first-time entering first-year students must report on Sunday 14 January 2007 for orientation, after which the registration of these students will take place according to a specific programme as from Wednesday 17 January 2007. The official welcoming functioning for new first-years at the Qwaqwa Campus of the UFS will take place on Saturday 10 February 2007 at 08:00 in the Rolihlahla Mandela Hall on the Qwaqwa Campus.
 
First-year students who have applied to study at the Qwaqwa Campus and their parents should attend this function which fulfils the same role as the one held on the Bloemfontein Main Campus.
 
Detailed information on the dates and times of registration for the various faculties and academic learning programmes is available on the UFS website at www.ufs.ac.za
 
Prospective students may also call the Main Campus in Bloemfontein on 051 4013000 or the Qwaqwa Campus on 058 718-5000 for more information.
 
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
11 January 2007
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept